Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Acta Oncologica (Stockholm, Sweden)|December 8, 2005
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy GroupBengt Glimelius, Olav Dahl, Björn Cedermark, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2009
Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I studyHåkan Andersson, Elin Cederkrantz, Tom Bäck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose EstimationsAndreas Hallqvist, Karin Bergmark, Tom Bäck, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer PatientsElin Cederkrantz, Håkan Andersson, Peter Bernhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed doseJörgen Elgqvist, Håkan Andersson, Tom Bäck, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2006
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, et al.
Acta Oncologica (Stockholm, Sweden)|May 7, 2002
Physical performance, toxicity, and quality of life as assessed by the physician and the patientMinna-Liisa Luoma, Liisa Hakamies-Blomqvist, Johanna Sjöström, et al.
Plos One|May 14, 2015
Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200Sture Lindegren, Luciana N S Andrade, Tom Bäck, et al.
Pageof 5